[HTML][HTML] Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance

Y Hu, Y Zhu, NH Lu - Frontiers in cellular and infection microbiology, 2017 - frontiersin.org
Helicobacter pylori (H. pylori) is a common gastrointestinal bacterial strain closely
associated with the incidence of chronic gastritis, peptic ulcers, gastric mucosa-associated …

Primary Antibiotic Resistance of Helicobacter pylori in China

Y Hu, Y Zhu, N Lu - Digestive diseases and sciences, 2017 - Springer
Abstract Background and Aims Antibiotic resistance is the most important factor leading to
the failure of eradication regimens; thus, it is important to obtain regional antibiotic …

[PDF][PDF] 第五次全国幽门螺杆菌感染处理共识报告

刘文忠, 谢勇, 陆红, 成虹, 曾志荣, 周丽雅, 陈烨… - 中华消化杂志, 2017 - file.medtrib.cn
由中华医学会消化病学分会幽门螺杆菌(Hp) 和消化性溃疡学组主办的“幽门螺杆菌感染处理
maastricht 5 共识研讨会暨第五次全国幽门螺杆菌感染处理共识会” 于2016 年12 月15~ 16 …

Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection

WZ Liu, Y Xie, H Lu, H Cheng, ZR Zeng, LY Zhou… - …, 2018 - Wiley Online Library
Abstract Background Since the 'Fourth Chinese National Consensus Report on the
management of H. pylori infection'was published in 2012, three important consensuses …

Eradication rates of Helicobacter pylori in treatment‐naive patients following 14‐day vonoprazan‐amoxicillin dual therapy: A multicenter randomized controlled trial in …

J Hu, H Mei, N Su, W Sun, D Zhang, L Fan, P He… - …, 2023 - Wiley Online Library
Background Potassium‐competitive acid blockers (P‐CAB) are recommended for the
treatment of Helicobacter pylori infections, but dual therapy of P‐CAB with amoxicillin has …

Bibliometric analysis of Helicobacter pylori resistance—from 2002 to 2022

M Li, N Gao, S Wang, Y Guo, Z Liu - Helicobacter, 2023 - Wiley Online Library
Abstract Background Drug resistance in Helicobacter pylori severely affects the efficacy of
eradication therapy, and a number of studies have been conducted on this issue. The aim of …

Furazolidone treatment for Helicobacter Pylori infection: A systematic review and meta‐analysis

L Zhuge, Y Wang, S Wu, RL Zhao, Z Li, Y Xie - Helicobacter, 2018 - Wiley Online Library
Antibiotic resistance is a major cause of Helicobacter pylori (H. pylori) treatment failures.
Because the resistance rate of H. pylori to furazolidone is low, we aimed to assess the …

中国幽门螺杆菌感染的现状

谢川, 吕农华 - 疾病监测, 2018 - jbjc.org
我国是幽门螺杆菌(HP) 高感染地区, HP 感染相关疾病负担(尤其是胃癌) 较重,
国内学术界应尽快统一认识, 重视HP 感染的危害, 建立有效的胃癌一, 二级预防体系; 同时 …

Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, China

T Geng, ZS Yu, XX Zhou, B Liu, HH Zhang… - European Journal of …, 2022 - Springer
The resistance of Helicobacter pylori (H. pylori) to antibiotics has been increasing worldwide
and varies across different geographic areas and times. Limited studies reported the …

Is tailored therapy based on antibiotic susceptibility effective? A multicenter, open-label, randomized trial

J Pan, Z Shi, D Lin, N Yang, F Meng, L Lin, Z Jin… - Frontiers of …, 2020 - Springer
An effective eradication therapy of Helicobacter pylori (H. pylori) should be used for the first
time. In this study, we assessed whether tailored therapy based on antibiotic susceptibility …